GET THE APP

Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

Citations Report

Citations Report - Journal of Leukemia [386 Articles]

The articles published in Journal of Leukemia have been cited 386 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Leukemia.

Shahjahani M, Mohammadiasl J, Noroozi F, Seghatoleslami M, Shahrabi S, et al.(2015) Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. Cellular Oncology. 38: 93-109.

Robak T, Robak P (2013) BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies. International reviews of immunology.32: 358-376.

テ青姪青クテ青エテ青オテ堕テ青コテ青クテ青ケ テ青静青. テ青テ青オテ堕テ青セテ青サテ青エテ青クテ青ステ青ウ テ堕テ青オテ青コテ青セテ青シテ青アテ青クテ青ステ青ーテ青ステ堕づ青ステ青セテ青ウテ青セ テ堕催青コテ堕づ青セテ青エテ青セテ青シテ青オテ青ステ青ー テ堕催堕テ堕テ青クテ青ステ青セテ青イテ青セテ青ウテ青セ (2015 テ堕テ青オテ堕テ青オテ青ソテ堕づ青セテ堕テ青ー テ堕づ青クテ青ソテ青ー テ青5. テ青 テ青「テ青テ青陛青・ テ青ァテ青静青。テ青「テ青ッテ青・.239.

Tomasevic N, Luehrsen K, Baer M, Palath V, Martinez D, et al.(2014 )A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity. Growth factors.32:223-35.

Charmsaz S, Beckett K, Smith FM, Bruedigam C, Moore AS, et al. (2015) EphA2 is a therapy target in EphA2-positive leukemias but is not essential for normal hematopoiesis or leukemia. PloS one. 10:e0130692.

Kagita S, Uppalapati S, Jiwatani S, Linga VG, Gundeti S, et al. (2014) Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India. Tumor Biology 35:7187-7193.

Relevant Topics

Top